孢子丝菌病

Rex JH, Okhuysen PC. Sporothrix schenckii. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2984-2987.

Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231-236.

• 摘要

Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000;30:65-70.

• 全文
• 摘要

Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 1993;118:883-888.

• 摘要

Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255-1265.

• 全文
• 摘要

Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med. 1993;95:279-285.

• 摘要

de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, et al. Treatment of cutaneous sporotrichosis with itraconazole - study of 645 patients. Clin Infect Dis. 2011;52:e200-e206.

• 全文
• 摘要

1.  Rex JH, Okhuysen PC. Sporothrix schenckii. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2984-2987.

2.  Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231-236.

• 摘要

3.  Appenzeller S, Amaral TN, Amstalden EM, et al. Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature. Clin Rheumatol. 2006;25:926-928.

• 摘要

4.  Crout JE, Brewer NS, Tompkins RB. Sporotrichosis arthritis: clinical features in seven patients. Ann Intern Med. 1977;86:294-297.

• 摘要

5.  Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore). 1986;65:143-153.

• 摘要

6.  Silva-Vergara ML, Maneira FR, De Oliveira RM, et al. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol. 2005;43:187-190.

• 摘要

7.  Hardman S, Stephenson I, Jenkins DR, et al. Disseminated Sporothix schenckii in a patient with AIDS. J Infect. 2005;51:e73-e77.

• 摘要

8.  al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26:1403-1406.

• 摘要

9.  da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52:451-459.

• 摘要

10.  Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000;30:65-70.

• 全文
• 摘要

11.  Barros MB, Schubach Ade O, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis. 2004;38:529-535.

• 全文
• 摘要

12.  Silva MB, Costa MM, Torres CC, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil. Cad Saude Publica. 2012;28:1867-1880.

• 全文
• 摘要

13.  Rudramurthy SM, Cano J, Chakrabarti A, et al. Sporothrix globosa: is the only described Sporothrix species causing human infections in India? 17th Congress of International Society for Human and Animal Mycology (ISHAM). Tokyo, Japan. 2009. Abstract #PP-06-58.

14.  Oliveira MM, Almeida-Paes R, Muniz MM, et al. Phenotypic and molecular identification of sporothrix isolates from an epidemic area of sporotrichosis in Brazil. Mycopathologia. 2011;172:257-267.

• 摘要

15.  Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis. 1979;139:424-431.

• 摘要

16.  Lückhoff A, Busse R. Refilling of endothelial calcium stores without bypassing the cytosol. FEBS Lett. 1990;276:108-110.

• 摘要

17.  Romo-Lozano Y, Hernández-Hernández F, Salinas E. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol. 2012;76:11-20.

• 摘要

18.  Sassá MF, Ferreira LS, de Abreu Ribeiro LC, et al. Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia. 2012;174:21-30.

• 摘要

19.  Li M, Chen Q, Sun J, et al. Inflammatory response of human keratinocytes triggered by Sporothrix schenckii via Toll-like receptor 2 and 4. J Dermatol Sci. 2012;66:80-82.

• 摘要

20.  Plouffe JF Jr, Silva J Jr, Fekety R, et al. Cell-mediated immune responses in sporotrichosis. J Infect Dis. 1979;139:152-157.

• 摘要

21.  Koga T, Duan H, Furue M. Immunohistochemical detection of interferon-gamma-producing cells in granuloma formation of sporotrichosis. Med Mycol. 2002;40:111-114.

• 摘要

22.  Boehm D, Lynch JM, Hodges GR, et al. Case report: disseminated sporotrichosis presenting as sarcoidosis: electron microscopic and immunologic studies. Am J Med Sci. 1982;283:71-78.

• 摘要

23.  Mayorga R, Cáceres A, Toriello C, et al. Study of an endemic sporotrichosis zone in the Ayarza lake region of Guatemala. Bol Oficina Sanit Panam. 1979;87:20-34.

• 摘要

24.  Moreira JA, Freitas DF, Lamas CC. The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection. 2015;43:267-276.

• 摘要

25.  Gottlieb GS, Lesser CF, Holmes KK, et al. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2003;37:838-840.

• 全文
• 摘要

26.  Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;176:499-504.

• 摘要

27.  Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 1993;118:883-888.

• 摘要

28.  Marques ME, Coelho KI, Sotto MN, et al. Comparison between histochemical and immunohistochemical methods for diagnosis of sporotrichosis. J Clin Pathol. 1992;45:1089-1093.

• 摘要

29.  Hu S, Chung WH, Hung SI, et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol. 2003;41:1414-1418.

• 全文
• 摘要

30.  Scott EN, Kaufman L, Brown AC, et al. Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii. N Engl J Med. 1987;317:935-940.

• 摘要

31.  Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255-1265.

• 全文
• 摘要

32.  Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med. 1993;95:279-285.

• 摘要

33.  Restrepo A, Robledo J, Gómez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol. 1986;122:413-417.

• 摘要

34.  Conti Díaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses. 1992;35:153-156.

• 摘要

35.  de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, et al. Treatment of cutaneous sporotrichosis with itraconazole - study of 645 patients. Clin Infect Dis. 2011;52:e200-e206.

• 全文
• 摘要

36.  Cabezas C, Bustamante B, Holgado W, et al. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996;15:352-354.

• 摘要

37.  Itoh M, Okamoto S, Kariya H. Survey of 200 cases of sporotrichosis. Dermatologica. 1986;172:209-213.

• 摘要

38.  Xue S, Gu R, Wu T, et al. Oral potassium iodide for the treatment of sporotrichosis. Cochrane Database Syst Rev. 2009;(4):CD006136. Review.

• 摘要

39.  Chapman SW, Pappas P, Kauffmann C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses. 2004;47:62-68.

• 摘要

40.  Francesconi G, Francesconi do Valle AC, Passos SL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011;171:349-454.

• 摘要

41.  Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996;22:46-50.

• 摘要

42.  Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis. 1993;17:210-217.

• 摘要

43.  Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96-128.

• 全文
• 摘要

44.  Hiruma M, Kawada A, Noguchi H, et al. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses. 1992;35:293-299.

• 摘要

45.  Hiruma M, Kagawa S. Effects of hyperthermia on phagocytosis and intracellular killing of Sporothrix schenckii by polymorphonuclear leukocytes. Mycopathologia. 1986;95:93-100.

• 摘要

46.  Hata M, Tatsuno K, Suzuki Y, et al. Successful treatment of sporotrichosis with voriconazole. 17th Congress of International Society for Human and Animal Mycology (ISHAM). Tokyo, Japan. 2009. Abstract #PP-03-12.

47.  Fernández-Silva F, Capilla J, Mayayo E, et al. Efficacy of posaconazole in murine experimental sporotrichosis. Antimicrob Agents Chemother. 2012;56:2273-2277.

• 摘要

48.  Espinel-Ingroff A. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 1998;36:2950-2956.

• 摘要

49.  Deray G. Amphotericin-B nephrotoxicity. J Antimicrob Chemother. 2002;49(suppl 1):S37-S41.

• 全文
• 摘要